Presentations and Publications

Read about publications and presentations made by Benitec's scientific team below. For details of Benitec's announcements to NASDAQ, read details in our Investor Centre.

2018

BB-301: A Single “Silence and Replace” AAV-Based Vector for the Treatment of Oculopharyngeal Muscular Dystrophy (OPMD)

The 21st Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Chicago

May 18, 2018

2017

Gene therapy for oculopharyngeal muscular dystrophy

The 22nd International Annual Congress of the World Muscle Society

Oct 6, 2017
PABPN1 gene therapy for oculopharyngeal muscular dystrophy

Nat. Commun. 8, 14848 doi: 10.1038/ ncomms14848 (2017)

Jan 1, 2017

2014

Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision

Molecular Therapy Nucleic Acids. 2014;3(2):e145-. doi:10.1038/mtna.2013.73

Jan 1, 2014

2012

In Vitro Characterization of the Activity of PF-05095808, a Novel Biological Agent for Hepatitis C Virus Therapy

Antimicrobial Agents and Chemotherapy. 2012; 56(3):1364-1375. doi:10.1128/AAC.05357-11

Jan 1, 2012
Safe, Long-term Hepatic Expression of Anti-HCV shRNA in a Nonhuman Primate Model

Molecular Therapy. 2012; 20(9):1737-1749. doi:10.1038/mt.2012.119

Jan 1, 2012